Quantcast Venaxis' APPY1 Test Passes Futility Analysis In Pivotal Clinical Study - Congoo
 
 
BIOTECH Log In
Venaxis' APPY1 Test Passes Futility Analysis in Pivotal Clinical Study
Have an interest in this Story?
Sign Up for Real-Time email updates
KRHD TV  | July 15, 2013

SOURCE Venaxis, Inc. Company Provides Clinical and Corporate Update Company to Host Conference Call and Webcast Tuesday, July 16, 2013, 8:30 a.m. ET CASTLE ROCK, Colo. The futility analysis, which consisted of an independent review of the validity, integrity, and clinical and scientific relevan...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Sylvia M. Romagosa, MBA Sylvia M. Romagosa, MBA
Licensed Real Estate Broker
Real Estate Industry
Lucill Alkabir Lucill Alkabir
Your Canadian Real Estate Connection in Tucson, AZ
Real Estate Industry

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2014 Congoo.com. All Rights Reserved.